NCT01406132View on ClinicalTrials.gov

A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Healthy SubjectsPharmacokinetics of ASP015K
Interventions
DRUG

ASP015K

oral

Trial Locations (1)

53704

Covance Clinical Research Unit (CCRU), Madison

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY